The pharmaceutical company Viking has recently become one of the most volatile stocks on Wall Street due to the announcement ...

In a report released yesterday, Joon Lee from Truist Financial maintained a Buy rating on Argenx Se (ARGX – Research Report), with a ...

Novo Nordisk's valuation remains high, trading at a significant historical premium. Click here to see why NVO stock is a Sell ...

Conference call with CEO Dr. Lian and CFO Zante to be held on November 5 at 11:30 am hosted by JPMorgan. Webcast Link Published first on ...

AstraZeneca PLC shed GBP15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company (UK:AZN) said its lead product ...

Vertex beat third-quarter expectations late Monday, but an analyst says Vertex stock needs more "to drive another leg of stock upside." ...

PicoCELA Inc. has filed to raise $10M in a U.S. IPO to fund inventory and product R&D. Click here for more on PCLA stock, and why my outlook on the IPO is to sell.

Viking Therapeutics announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.